• Ring Therapeutics rounds up $117M to find better viral vectors for gene therapy

    1 month ago - By MedCity News

    The engineered viruses used to deliver gene therapies can spark complications and they can't be re-dosed. Ring Therapeutics says viruses that evolved with humans can be better viral vectors and the startup has raised $117 million in new financing to continue its research.
    Read more ...